ANDA 83215, held by Upsher-Smith Laboratories. Brompheniramine Maleate.
As of Nov 21, 2026, ANDA 83215 (Brompheniramine Maleate), held by Upsher-Smith Laboratories, was first approved by FDA on Dec 19, 1975, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 19, 1975 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Brompheniramine Maleate4MG · tablet;oral | Brompheniramine Maleate | Discontinued |
| Sep 30, 1982 | Supplement 29Manufacturing | Approved | None posted |
| Jul 8, 1982 | Supplement 28Manufacturing | Approved | None posted |
| Jul 1, 1982 | Supplement 26Manufacturing | Approved | None posted |
| Jul 1, 1982 | Supplement 27Manufacturing | Approved | None posted |
| Apr 15, 1982 | Supplement 25Manufacturing | Approved | None posted |
| Dec 19, 1975 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters